References
- Sociedad Latinoamericana de Infectología Pediátrico (SLIPE). Calendario de Vacunación Recomendado para las Personas de 0 a 18 Años de Edad. [cited 2020 Jun 03]. https://slipe.org/slipe-calendario.html
- Waggoner J, Carline J, Durning S. Is There a Consensus on Consensus Methodology? Descriptions and Recommendations for Future Consensus Research. Acad Med. 2016;91(5):663–668.
- Pan American Health Organization. No polio in the Americas for two years. PAHO/EPI Newsl. 1993;15(4):1–2.
- World Health Organization. Polio Vaccines: WHO Position Paper, March 2016. Wkly Epidemiol Rec. 2016;91(12):145–168.
- Sutter RW, Kew OM, Cochi SL, et al. Poliovirus vaccine - live. In: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. Vol. 28. 6th ed. USA: Saunders Elsevier. Inc.; 2012. p. 598–645.
- John TJ, Vashishtha VM. Eradicating poliomyelitis: India’s journey from hyperendemic to polio-free status. Indian J Med Res. 2013;137(5):881–894.
- Platt LR, Estívariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014;210(suppl 1):S380–9.
- World Health Organization. Polio Eradication & Endgame Strategic Plan 2013-2018. [cited 2020 Jun 02]. http://polioeradication.org/wp-content/uploads/2016/07/PEESP_EN_A4.pdf
- Classification and reporting of vaccine-derived polioviruses (VDPV) GPEI guidelines. August 2016. [cited 2020 Jun 06]. http://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf
- World Health Organization. Polio Global Eradication Initiative. Polio Now. [cited 2020 Jun 02]. http://polioeradication.org/polio-today/polio-now/
- Pírez MC, Olivera I, Diabarboure H, et al. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies. Vaccine. 2009;27(20):2689–2694.
- Jaramillo A, Richardson López-Collada VL. Towards the eradication of poliomyelitis: Mexico’s achievements and challenges. Salud Publica Mex. 2012;54(5):537–543.
- Polio Global Eradication Initiative. Polio this week as of December 3, 2019. [cited 2020 May 30]. http://polioeradication.org/polio-today/polio-now/this-week/
- Implementation of fractional doses of the inactivated poliovirus vaccine. WHO/PAHO 2017. ( fIPV). [cited 2020 Jun 01]. https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=guides-training-material-7348&alias=43022-implementation-fractional-doses-inactivated-poliovirus-vaccine-fipv-022&Itemid=270&lang=en>
- Domingues CM, de Fátima Pereira S, Cunha Marreiros AC, et al. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil’s National Immunization Program. J Infect Dis. 2014;210(Suppl 1):S143–S151.
- Arbo A, Falleiros-Arlant LH, López EL, et al. Remarks on the possibility of the introduction of fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule. Rev Chilena Infectol. 2018;35:395–402.
- Bahl S, Verma H, Bhatnagar P, et al. Fractional-dose inactivated poliovirus vaccine immunization campaign - Telangana state, India, June 2016. MMWR Morb Mortal Wkly Rep. 2016;65. DOI:859–63.doi:10.15585/mmwr.mm6533a5.
- Poliovirus Surveillance among patients with Primary Immunodeficiency Disorders (PIDs) Introduction of new guidelines. For the SAGE Meeting, April 3, 2019. [cited 2020 May 29]. https://www.who.int/immunization/sage/meetings/2019/april/2_SAGE_April_2019_polio_Mach.pdf
- Hozbor D, Ulloa-Gutierrez R, Marino C, et al. Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meeting. Vaccine. 2019;37(36):5414–5421.
- Falleiros-Arlant LH, de Colsa A, Flores D, et al. Pertussis in Latin America: epidemiology and control strategies. Expert Rev Anti Infect Ther. 2014;12(10):1265–1275.
- Folaranmi T, Pinell-McNamara V, Griffith M, et al. Systematic review and meta-analysis of pertussis epidemiology in Latin America and the Caribbean: 1980–2015. Rev Panam Salud Publica. 2017;41:e102.
- Pinell-McNamara VA, Acosta AM, Pedreira MC, et al. Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project. Emerg Infect Dis. 2017;23(13):S94–S100.
- PAHO. Immunization: data maps and statistics. [cited 2020 May 28]. https://www.paho.org/hq/index.php?option=com_topics&view=rdmore&cid=1639&Itemid=40242&lang=en=
- Pan American Health Organization. Final report. Proceedings of the XXI Technical Advisory Group (TAG) meeting on vaccine-preventable diseases in Quito, Ecuador, 2013 Jul 3-5. Washington DC: PAHO; 2015. http://www2.paho.org/hq/index.php?option=com_content&view=article&id=1862%3Atechnicaladvisory-group-vaccine-preventable-diseases&catid=1549%3Ainformation-products&Itemid=39430&lang=en
- Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):1–44.
- Campbell H, Gupta S, Dolan GP, et al. Review of vaccination in pregnancy to prevent pertussis in early infancy. J Med Microbiol. 2018;67(10):1426–1456.
- Vizzotti C, Neyro S, Katz N, et al. Maternal immunization in Argentina: A storyline from the prospective of a middle income country. Vaccine. 2015;33(47):6413–6419.
- Fabricius G, Bergero PE, Ormazabal ME, et al. Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina. Epidemiol Infect. 2013;141(4):718–734..
- WHO vaccine-preventable diseases: monitoring system. 2019 Global summary. [cited 2020 May 29]. http://apps.who.int/immunization_monitoring/globalsummary/schedules
- PAHO. Immunization: data maps and statistics. [cited 2020 Jun 1]. https://www.paho.org/hq/index.php?option=com_topics&view=rdmore&cid=1639&Itemid=40242&lang=en
- Roman S, Jose-Abrego A, Fierro NA, et al. Hepatitis B virus infection in Latin America: A genomic medicine approach. World J Gastroenterol. 2014;20(23):7181–7196.
- Ropero Álvarez AM, Pérez-Vilar S, Pacis-Tirso C, et al. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas. BMC Public Health. 2017;17(1):325.
- DeAntonio R, Amador S, Bunge EM, et al. Vaccination herd effect experience in Latin America: a systematic literature review. Hum Vaccin Immunother. 2018;15(1):49–71.
- Montano A, Algorta G, Pírez C, et al. Enfermedades invasivas por Haemophilus influenzae tipo b. Impacto de la vacunación en los niños que ingresan al Centro Hospitalario Pereira Rossell. Rev Méd Urug. 2001;17:166–170.
- Dickinson Meneses FO, Pérez Rodríguez AE. Las meningoencefalitis bacterianas en la población infantil cubana: 1998-2000. Revista Cub Ped. 2002;72:106–114.
- Kmetzsch CI, Schermann MT, Santana JC, et al. Occurrence of Haemophylus influenzae B meningitis after the implementation of a mass vaccination program]. J Pediatr (Rio J). 2003;79(6):530–536.
- Miranzi SS, Moraes SA, Freitas IC. Trends in Haemophilus influenzae type b meningitis in Brazil in children under five years of age from 1983 through 2002. Rev Soc Bras Med Trop. 2006;39:473–477.
- Decker, et al. Combination vaccines. In: Plotkin's Vaccines. 7th. New York, NY: Elselvier; 2018. 198–227.
- WHO vaccine-preventable diseases: monitoring system. Global summary. 2019. [cited 2020 May 31]. http://apps.who.int/immunization_monitoring/globalsummary/
- Polio vaccines: WHO position paper. March, 2016. [cited 2020 Jun 3]. https://www.who.int/wer/2016/wer9112.pdf?ua=1
- PAHO Vaccine introduction. [cited 2020 Jun 2]. http://phip.paho.org/views/PLISA_vaccine_introduction_en/Table?:embed=y&:showAppBanner=false&:showShareOptions=true&:display_count=no&:showVizHome=no#1
- Tauil MC, Sato AP, Waldman EA. Factors associated with incomplete or delayed vaccination across countries: A systematic review. Vaccine. 2016;34(24):2635–2643.
- Kalies H, Grote V, Verstraeten T, et al. The use of combination vaccines has improved timeliness of vaccination in Children. Pediatr Infect Dis J. 2006;25(6):507–512.
- Marshall G, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496–500.
- Maman K, Zollner Y, Greco D, et al. The value of childhood combination vaccines. From beliefs to evidence. Hum Vaccin Immunother. 2015 September;11(9):2132–2141.
- Martins RM, Camacho LA, Lemoset M, et al. Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program. J Pediatr (Rio J). 2007;83(6):523–528.
- Beyazonova U, Yüksel N, Aksakal FN, et al. Comparison of the reactogenicity of three different immunization schedules including diphtheria, tetanus, pertussis, Haemophilus influenza b and polio vaccine in Turkey. Trans R Soc Trop Med Hyg. 2013;107: 438–443.
- Aquino AG, Brito MG, Doniz CE, et al. A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children. Vaccine. 2012;30(45):6492–6500.
- Lopez P, Mohs AA, Vasquez AA, et al. A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccination of Healthy Infants and Toddlers in Latin America. Pediatr Infect Dis J. 2017;36(11):e272–e282.
- Kosalaraksa P, Chokephaibulkit K, Benjaponpitak S, et al. Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP~T vaccination at 2, 4 and 6 months. Hum Vaccin Immunother. 2018;14(5):1257–1265.
- De Coster I, Fournie X, Faure C, et al. Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study. A time and motion study. Vaccine. 2015;33(32):3976–3982.
- Lloyd AJ, Nafees B, Ziani E, et al. What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution? Patient Prefer Adherence. 2015;9:1517–1524.
- Guzman-Holst A, De Antonio R, Prado-Cohrs D, et al. Barriers to vaccination in Latin America: A systematic literature review. Vaccine. 2020;38(3):470–481.